Cabasag, Helen M.

HRN: 10-03-66  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2026
CEFTRIAXONE 1G (VIAL)
04/30/2026
05/07/2026
IV
2g
Q24
Cap MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: